SCHEMBL32690706

SCHEMBL32690706

Nc1ccc2[nH]c(-c3ccccc3C(F)(F)F)c(O)c(=O)c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 2/20 0.51
▸ PARP1 P09874 1/20 0.45
▸ CDK5 Q00535 3/20 0.44
▸ CDK5R1 Q15078 3/20 0.44
▸ CCNB2 O95067 2/20 0.44
▸ CDK1 P06493 2/20 0.44
▸ CCNB1 P14635 2/20 0.44
▸ GSK3B P49841 2/20 0.44
▸ CCNB3 Q8WWL7 2/20 0.44
▸ CHEK1 O14757 1/20 0.43
▸ WEE1 P30291 1/20 0.43
▸ STK17B O94768 1/20 0.41
▸ FLT3 P36888 1/20 0.41
▸ KIF11 P52732 2/20 0.39
▸ PDE10A Q9Y233 1/20 0.39
▸ GAA P10253 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CASP6 P55212 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32690833 0.90 AR (0.51) ARPARP1CDK5CDK5R1CCNB2
SCHEMBL32690692 0.85 CHEK1 (0.43) ARCDK5CDK5R1CCNB2CDK1
SCHEMBL32690670 0.84 PARP1 (0.48) ARPARP1CDK5CDK5R1CCNB2
SCHEMBL32690742 0.81 CTSV (0.55) PARP1CDK5CDK5R1CCNB2CDK1
SCHEMBL32690798 0.81 PARP1 (0.48) PARP1CDK5CDK5R1CCNB2CDK1
SCHEMBL32690789 0.79 POLB (0.46) PARP1CHEK1WEE1KIF11PDE10A
SCHEMBL23270975 0.79 TRPA1 (0.44) GAAMEN1POLBKMT2ATDP1
SCHEMBL32690672 0.78 PTGES (0.44) CDK5CDK5R1CCNB2CDK1CCNB1
Hydrochloric Acid SCHEMBL23271094 0.78 TRPA1 (0.43) GAAMEN1POLBKMT2ATDP1
SCHEMBL32690700 0.77 PARP1 (0.40) ARPARP1CHEK1WEE1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US claimed
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition NOX1, NOX4, CYBB AR 532/4885PARP1 113/4885CDK5 1932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback